nodes	percent_of_prediction	percent_of_DWPC	metapath
Bendroflumethiazide—KCNMA1—gall bladder—pancreatic cancer	0.0378	0.172	CbGeAlD
Bendroflumethiazide—TPMT—islet of Langerhans—pancreatic cancer	0.0266	0.121	CbGeAlD
Bendroflumethiazide—KCNMA1—islet of Langerhans—pancreatic cancer	0.0248	0.113	CbGeAlD
Bendroflumethiazide—Drug interaction—Tamoxifen—pancreatic cancer	0.0236	0.0303	CcSEcCtD
Bendroflumethiazide—Drug interaction—Erlotinib—pancreatic cancer	0.0234	0.03	CcSEcCtD
Bendroflumethiazide—Blood disorder—Sunitinib—pancreatic cancer	0.0225	0.0288	CcSEcCtD
Bendroflumethiazide—TPMT—pancreas—pancreatic cancer	0.0187	0.0851	CbGeAlD
Bendroflumethiazide—CA2—gall bladder—pancreatic cancer	0.0186	0.0846	CbGeAlD
Bendroflumethiazide—KCNMA1—pancreas—pancreatic cancer	0.0174	0.0791	CbGeAlD
Bendroflumethiazide—Thirst—Tamoxifen—pancreatic cancer	0.0167	0.0214	CcSEcCtD
Bendroflumethiazide—Drug interaction—Gemcitabine—pancreatic cancer	0.0162	0.0208	CcSEcCtD
Bendroflumethiazide—CA4—islet of Langerhans—pancreatic cancer	0.0147	0.0669	CbGeAlD
Bendroflumethiazide—Cramp muscle—Tamoxifen—pancreatic cancer	0.0143	0.0184	CcSEcCtD
Bendroflumethiazide—Hypokalaemia—Erlotinib—pancreatic cancer	0.0143	0.0184	CcSEcCtD
Bendroflumethiazide—Pancreatitis—Tamoxifen—pancreatic cancer	0.0135	0.0173	CcSEcCtD
Bendroflumethiazide—Pancreatitis—Erlotinib—pancreatic cancer	0.0133	0.0171	CcSEcCtD
Bendroflumethiazide—CA1—pancreas—pancreatic cancer	0.0132	0.0601	CbGeAlD
Bendroflumethiazide—Erectile dysfunction—Tamoxifen—pancreatic cancer	0.0127	0.0162	CcSEcCtD
Bendroflumethiazide—Hypokalaemia—Sunitinib—pancreatic cancer	0.0124	0.0159	CcSEcCtD
Bendroflumethiazide—CA2—islet of Langerhans—pancreatic cancer	0.0122	0.0554	CbGeAlD
Bendroflumethiazide—Pancreatitis—Sunitinib—pancreatic cancer	0.0116	0.0148	CcSEcCtD
Bendroflumethiazide—Drug interaction—Docetaxel—pancreatic cancer	0.0115	0.0148	CcSEcCtD
Bendroflumethiazide—CA1—digestive system—pancreatic cancer	0.0113	0.0513	CbGeAlD
Bendroflumethiazide—Orthostatic hypotension—Irinotecan—pancreatic cancer	0.0103	0.0131	CcSEcCtD
Bendroflumethiazide—Hypokalaemia—Irinotecan—pancreatic cancer	0.0102	0.0131	CcSEcCtD
Bendroflumethiazide—Cramp muscle—Irinotecan—pancreatic cancer	0.0101	0.013	CcSEcCtD
Bendroflumethiazide—Hypokalaemia—Gemcitabine—pancreatic cancer	0.00995	0.0128	CcSEcCtD
Bendroflumethiazide—Pancreatitis—Irinotecan—pancreatic cancer	0.00952	0.0122	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Tamoxifen—pancreatic cancer	0.00922	0.0118	CcSEcCtD
Bendroflumethiazide—CA4—digestive system—pancreatic cancer	0.00883	0.0401	CbGeAlD
Bendroflumethiazide—Blood disorder—Epirubicin—pancreatic cancer	0.00864	0.0111	CcSEcCtD
Bendroflumethiazide—CA2—pancreas—pancreatic cancer	0.00857	0.039	CbGeAlD
Bendroflumethiazide—Blood disorder—Doxorubicin—pancreatic cancer	0.00799	0.0102	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Sunitinib—pancreatic cancer	0.00789	0.0101	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Tamoxifen—pancreatic cancer	0.00766	0.00982	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Erlotinib—pancreatic cancer	0.00758	0.00971	CcSEcCtD
Bendroflumethiazide—Anorexia—Tamoxifen—pancreatic cancer	0.00746	0.00956	CcSEcCtD
Bendroflumethiazide—Anorexia—Erlotinib—pancreatic cancer	0.00738	0.00946	CcSEcCtD
Bendroflumethiazide—CA2—digestive system—pancreatic cancer	0.00732	0.0333	CbGeAlD
Bendroflumethiazide—Orthostatic hypotension—Docetaxel—pancreatic cancer	0.00709	0.00909	CcSEcCtD
Bendroflumethiazide—Cramp muscle—Docetaxel—pancreatic cancer	0.00699	0.00896	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Tamoxifen—pancreatic cancer	0.0068	0.00872	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Erlotinib—pancreatic cancer	0.00673	0.00862	CcSEcCtD
Bendroflumethiazide—Constipation—Tamoxifen—pancreatic cancer	0.00669	0.00858	CcSEcCtD
Bendroflumethiazide—Constipation—Erlotinib—pancreatic cancer	0.00662	0.00848	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Sunitinib—pancreatic cancer	0.00656	0.00841	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Irinotecan—pancreatic cancer	0.0065	0.00833	CcSEcCtD
Bendroflumethiazide—Anorexia—Sunitinib—pancreatic cancer	0.00639	0.00819	CcSEcCtD
Bendroflumethiazide—Diabetes mellitus—Epirubicin—pancreatic cancer	0.00602	0.00772	CcSEcCtD
Bendroflumethiazide—Vascular purpura—Epirubicin—pancreatic cancer	0.00585	0.0075	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Sunitinib—pancreatic cancer	0.00582	0.00747	CcSEcCtD
Bendroflumethiazide—Constipation—Sunitinib—pancreatic cancer	0.00573	0.00734	CcSEcCtD
Bendroflumethiazide—Asthenia—Tamoxifen—pancreatic cancer	0.00561	0.00719	CcSEcCtD
Bendroflumethiazide—Diabetes mellitus—Doxorubicin—pancreatic cancer	0.00557	0.00714	CcSEcCtD
Bendroflumethiazide—Asthenia—Erlotinib—pancreatic cancer	0.00555	0.00712	CcSEcCtD
Bendroflumethiazide—Purpura—Epirubicin—pancreatic cancer	0.00543	0.00696	CcSEcCtD
Bendroflumethiazide—Vascular purpura—Doxorubicin—pancreatic cancer	0.00542	0.00694	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Irinotecan—pancreatic cancer	0.0054	0.00693	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Tamoxifen—pancreatic cancer	0.00535	0.00686	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Erlotinib—pancreatic cancer	0.0053	0.00679	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.00526	0.00675	CcSEcCtD
Bendroflumethiazide—Anorexia—Irinotecan—pancreatic cancer	0.00526	0.00674	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.00518	0.00663	CcSEcCtD
Bendroflumethiazide—Dizziness—Tamoxifen—pancreatic cancer	0.00517	0.00663	CcSEcCtD
Bendroflumethiazide—Hypotension—Irinotecan—pancreatic cancer	0.00516	0.00661	CcSEcCtD
Bendroflumethiazide—Anorexia—Gemcitabine—pancreatic cancer	0.00512	0.00657	CcSEcCtD
Bendroflumethiazide—Dizziness—Erlotinib—pancreatic cancer	0.00512	0.00656	CcSEcCtD
Bendroflumethiazide—Anorexia—Fluorouracil—pancreatic cancer	0.00504	0.00646	CcSEcCtD
Bendroflumethiazide—Purpura—Doxorubicin—pancreatic cancer	0.00503	0.00644	CcSEcCtD
Bendroflumethiazide—Hypotension—Gemcitabine—pancreatic cancer	0.00502	0.00644	CcSEcCtD
Bendroflumethiazide—Vomiting—Tamoxifen—pancreatic cancer	0.00497	0.00638	CcSEcCtD
Bendroflumethiazide—Hypotension—Fluorouracil—pancreatic cancer	0.00494	0.00633	CcSEcCtD
Bendroflumethiazide—Rash—Tamoxifen—pancreatic cancer	0.00493	0.00632	CcSEcCtD
Bendroflumethiazide—Dermatitis—Tamoxifen—pancreatic cancer	0.00493	0.00632	CcSEcCtD
Bendroflumethiazide—Vomiting—Erlotinib—pancreatic cancer	0.00492	0.00631	CcSEcCtD
Bendroflumethiazide—Rash—Erlotinib—pancreatic cancer	0.00488	0.00626	CcSEcCtD
Bendroflumethiazide—Dermatitis—Erlotinib—pancreatic cancer	0.00488	0.00625	CcSEcCtD
Bendroflumethiazide—Asthenia—Sunitinib—pancreatic cancer	0.00481	0.00616	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Irinotecan—pancreatic cancer	0.0048	0.00615	CcSEcCtD
Bendroflumethiazide—Orthostatic hypotension—Epirubicin—pancreatic cancer	0.00478	0.00613	CcSEcCtD
Bendroflumethiazide—Hypokalaemia—Epirubicin—pancreatic cancer	0.00476	0.00611	CcSEcCtD
Bendroflumethiazide—Constipation—Irinotecan—pancreatic cancer	0.00472	0.00605	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Gemcitabine—pancreatic cancer	0.00467	0.00599	CcSEcCtD
Bendroflumethiazide—Nausea—Tamoxifen—pancreatic cancer	0.00465	0.00596	CcSEcCtD
Bendroflumethiazide—Constipation—Gemcitabine—pancreatic cancer	0.0046	0.00589	CcSEcCtD
Bendroflumethiazide—Nausea—Erlotinib—pancreatic cancer	0.0046	0.00589	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Fluorouracil—pancreatic cancer	0.0046	0.00589	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Sunitinib—pancreatic cancer	0.00458	0.00588	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Docetaxel—pancreatic cancer	0.00449	0.00576	CcSEcCtD
Bendroflumethiazide—Pancreatitis—Epirubicin—pancreatic cancer	0.00444	0.00569	CcSEcCtD
Bendroflumethiazide—Dizziness—Sunitinib—pancreatic cancer	0.00443	0.00568	CcSEcCtD
Bendroflumethiazide—Orthostatic hypotension—Doxorubicin—pancreatic cancer	0.00442	0.00567	CcSEcCtD
Bendroflumethiazide—Hypokalaemia—Doxorubicin—pancreatic cancer	0.00441	0.00565	CcSEcCtD
Bendroflumethiazide—Vomiting—Sunitinib—pancreatic cancer	0.00426	0.00546	CcSEcCtD
Bendroflumethiazide—Rash—Sunitinib—pancreatic cancer	0.00422	0.00542	CcSEcCtD
Bendroflumethiazide—Dermatitis—Sunitinib—pancreatic cancer	0.00422	0.00541	CcSEcCtD
Bendroflumethiazide—Pancreatitis—Doxorubicin—pancreatic cancer	0.00411	0.00526	CcSEcCtD
Bendroflumethiazide—Nausea—Sunitinib—pancreatic cancer	0.00398	0.0051	CcSEcCtD
Bendroflumethiazide—Asthenia—Irinotecan—pancreatic cancer	0.00396	0.00508	CcSEcCtD
Bendroflumethiazide—Asthenia—Gemcitabine—pancreatic cancer	0.00386	0.00494	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Irinotecan—pancreatic cancer	0.00378	0.00484	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Docetaxel—pancreatic cancer	0.00374	0.00479	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Gemcitabine—pancreatic cancer	0.00368	0.00472	CcSEcCtD
Bendroflumethiazide—Dizziness—Irinotecan—pancreatic cancer	0.00365	0.00468	CcSEcCtD
Bendroflumethiazide—Anorexia—Docetaxel—pancreatic cancer	0.00364	0.00466	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Fluorouracil—pancreatic cancer	0.00362	0.00464	CcSEcCtD
Bendroflumethiazide—Hypotension—Docetaxel—pancreatic cancer	0.00357	0.00457	CcSEcCtD
Bendroflumethiazide—Vomiting—Irinotecan—pancreatic cancer	0.00351	0.0045	CcSEcCtD
Bendroflumethiazide—Dizziness—Fluorouracil—pancreatic cancer	0.0035	0.00448	CcSEcCtD
Bendroflumethiazide—Rash—Irinotecan—pancreatic cancer	0.00348	0.00446	CcSEcCtD
Bendroflumethiazide—Dermatitis—Irinotecan—pancreatic cancer	0.00348	0.00446	CcSEcCtD
Bendroflumethiazide—Vomiting—Gemcitabine—pancreatic cancer	0.00342	0.00438	CcSEcCtD
Bendroflumethiazide—Rash—Gemcitabine—pancreatic cancer	0.00339	0.00435	CcSEcCtD
Bendroflumethiazide—Dermatitis—Gemcitabine—pancreatic cancer	0.00339	0.00434	CcSEcCtD
Bendroflumethiazide—Vomiting—Fluorouracil—pancreatic cancer	0.00336	0.00431	CcSEcCtD
Bendroflumethiazide—Rash—Fluorouracil—pancreatic cancer	0.00333	0.00427	CcSEcCtD
Bendroflumethiazide—Dermatitis—Fluorouracil—pancreatic cancer	0.00333	0.00427	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Docetaxel—pancreatic cancer	0.00332	0.00425	CcSEcCtD
Bendroflumethiazide—Nausea—Irinotecan—pancreatic cancer	0.00328	0.0042	CcSEcCtD
Bendroflumethiazide—Constipation—Docetaxel—pancreatic cancer	0.00326	0.00418	CcSEcCtD
Bendroflumethiazide—Nausea—Gemcitabine—pancreatic cancer	0.00319	0.00409	CcSEcCtD
Bendroflumethiazide—Nausea—Fluorouracil—pancreatic cancer	0.00314	0.00402	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Epirubicin—pancreatic cancer	0.00303	0.00389	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Doxorubicin—pancreatic cancer	0.0028	0.0036	CcSEcCtD
Bendroflumethiazide—Asthenia—Docetaxel—pancreatic cancer	0.00274	0.00351	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Docetaxel—pancreatic cancer	0.00261	0.00335	CcSEcCtD
Bendroflumethiazide—Dizziness—Docetaxel—pancreatic cancer	0.00252	0.00323	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Epirubicin—pancreatic cancer	0.00252	0.00323	CcSEcCtD
Bendroflumethiazide—Anorexia—Epirubicin—pancreatic cancer	0.00245	0.00314	CcSEcCtD
Bendroflumethiazide—Vomiting—Docetaxel—pancreatic cancer	0.00243	0.00311	CcSEcCtD
Bendroflumethiazide—Rash—Docetaxel—pancreatic cancer	0.00241	0.00308	CcSEcCtD
Bendroflumethiazide—Hypotension—Epirubicin—pancreatic cancer	0.0024	0.00308	CcSEcCtD
Bendroflumethiazide—Dermatitis—Docetaxel—pancreatic cancer	0.0024	0.00308	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.00233	0.00299	CcSEcCtD
Bendroflumethiazide—Anorexia—Doxorubicin—pancreatic cancer	0.00227	0.00291	CcSEcCtD
Bendroflumethiazide—Nausea—Docetaxel—pancreatic cancer	0.00227	0.0029	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Epirubicin—pancreatic cancer	0.00224	0.00287	CcSEcCtD
Bendroflumethiazide—Hypotension—Doxorubicin—pancreatic cancer	0.00222	0.00285	CcSEcCtD
Bendroflumethiazide—Constipation—Epirubicin—pancreatic cancer	0.0022	0.00282	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Doxorubicin—pancreatic cancer	0.00207	0.00265	CcSEcCtD
Bendroflumethiazide—Constipation—Doxorubicin—pancreatic cancer	0.00204	0.00261	CcSEcCtD
Bendroflumethiazide—Asthenia—Epirubicin—pancreatic cancer	0.00185	0.00237	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Epirubicin—pancreatic cancer	0.00176	0.00226	CcSEcCtD
Bendroflumethiazide—Asthenia—Doxorubicin—pancreatic cancer	0.00171	0.00219	CcSEcCtD
Bendroflumethiazide—Dizziness—Epirubicin—pancreatic cancer	0.0017	0.00218	CcSEcCtD
Bendroflumethiazide—Vomiting—Epirubicin—pancreatic cancer	0.00164	0.0021	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Doxorubicin—pancreatic cancer	0.00163	0.00209	CcSEcCtD
Bendroflumethiazide—Rash—Epirubicin—pancreatic cancer	0.00162	0.00208	CcSEcCtD
Bendroflumethiazide—Dermatitis—Epirubicin—pancreatic cancer	0.00162	0.00208	CcSEcCtD
Bendroflumethiazide—Dizziness—Doxorubicin—pancreatic cancer	0.00157	0.00202	CcSEcCtD
Bendroflumethiazide—Nausea—Epirubicin—pancreatic cancer	0.00153	0.00196	CcSEcCtD
Bendroflumethiazide—Vomiting—Doxorubicin—pancreatic cancer	0.00151	0.00194	CcSEcCtD
Bendroflumethiazide—Rash—Doxorubicin—pancreatic cancer	0.0015	0.00192	CcSEcCtD
Bendroflumethiazide—Dermatitis—Doxorubicin—pancreatic cancer	0.0015	0.00192	CcSEcCtD
Bendroflumethiazide—Nausea—Doxorubicin—pancreatic cancer	0.00141	0.00181	CcSEcCtD
